Emerging antiviral resistance

doi:10.1038/s41564-019-0639-7

Comment

. 2020 Jan;5(1):4-5.

doi: 10.1038/s41564-019-0639-7.

Emerging antiviral resistance

Karen A Kormuth¹, Seema S Lakdawala^{2

3}

Affiliations

¹ Biology Department, Bethany College, Bethany, WV, USA.
² Department of Microbiology & Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Lakdawala@pitt.edu.
³ Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Lakdawala@pitt.edu.

PMID: 31857727
DOI: 10.1038/s41564-019-0639-7

Comment

Emerging antiviral resistance

Karen A Kormuth et al. Nat Microbiol. 2020 Jan.

. 2020 Jan;5(1):4-5.

doi: 10.1038/s41564-019-0639-7.

Authors

Karen A Kormuth¹, Seema S Lakdawala^{2

3}

Affiliations

¹ Biology Department, Bethany College, Bethany, WV, USA.
² Department of Microbiology & Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Lakdawala@pitt.edu.
³ Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Lakdawala@pitt.edu.

PMID: 31857727
DOI: 10.1038/s41564-019-0639-7

No abstract available

PubMed Disclaimer

Comment on

Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets.
Imai M, Yamashita M, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Kiso M, Murakami J, Yasuhara A, Takada K, Ito M, Nakajima N, Takahashi K, Lopes TJS, Dutta J, Khan Z, Kriti D, van Bakel H, Tokita A, Hagiwara H, Izumida N, Kuroki H, Nishino T, Wada N, Koga M, Adachi E, Jubishi D, Hasegawa H, Kawaoka Y. Imai M, et al. Nat Microbiol. 2020 Jan;5(1):27-33. doi: 10.1038/s41564-019-0609-0. Epub 2019 Nov 25. Nat Microbiol. 2020. PMID: 31768027

Cited by

Edible Plant Sprouts: Health Benefits, Trends, and Opportunities for Novel Exploration.
Aloo SO, Ofosu FK, Kilonzi SM, Shabbir U, Oh DH. Aloo SO, et al. Nutrients. 2021 Aug 21;13(8):2882. doi: 10.3390/nu13082882. Nutrients. 2021. PMID: 34445042 Free PMC article. Review.
Advancements in Antiviral Drug Development: Comprehensive Insights into Design Strategies and Mechanisms Targeting Key Viral Proteins.
Hangyu W, Panpan L, Jie S, Hongyan W, Linmiao W, Kangning H, Yichen S, Shuai W, Cheng W. Hangyu W, et al. J Microbiol Biotechnol. 2024 Jul 28;34(7):1376-1384. doi: 10.4014/jmb.2403.03008. Epub 2024 Apr 29. J Microbiol Biotechnol. 2024. PMID: 38934770 Free PMC article. Review.
Facial Synthesis and Bioevaluation of Well-Defined OEGylated Betulinic Acid-Cyclodextrin Conjugates for Inhibition of Influenza Infection.
Chen Y, Wang X, Ma X, Liang S, Gao Q, Tretyakova EV, Zhang Y, Zhou D, Xiao S. Chen Y, et al. Molecules. 2022 Feb 9;27(4):1163. doi: 10.3390/molecules27041163. Molecules. 2022. PMID: 35208962 Free PMC article.
Evaluation of cytotoxicity and antiviral activity of Rhazya stricta Decne leaves extract against influenza A/PR/8/34 (H1N1).
Albeshri A, Baeshen NA, Bouback TA, Aljaddawi AA. Albeshri A, et al. Saudi J Biol Sci. 2022 Sep;29(9):103375. doi: 10.1016/j.sjbs.2022.103375. Epub 2022 Jul 16. Saudi J Biol Sci. 2022. PMID: 35935104 Free PMC article.
Differentiation of CD166-positive hPSC-derived lung progenitors into airway epithelial cells.
Goh KJ, Lu H, Tan EK, Lee ZY, Wong A, Tran T, Dunn NR, Roy S. Goh KJ, et al. Biol Open. 2024 Jul 15;13(10):bio061729. doi: 10.1242/bio.061729. Epub 2024 Oct 10. Biol Open. 2024. PMID: 39387302 Free PMC article.

See all "Cited by" articles

References

1. Lee, N. & Hurt, A. C. Curr. Opin. Infect. Dis. 31, 520–526 (2018). - DOI
1. Shtyrya, Y. A., Mochalova, L. V. & Bovin, N. V. Acta Naturae 2, 26–32 (2009). - DOI
1. FDA approves new drug to treat influenza. U. S. Food and Drug Administration https://www.fda.gov/news-events/press-announcements/fda-approves-new-dru... (2018).
1. Imai, M. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-019-0609-0 (2019).
1. Omoto, S. et al. Sci. Rep. 8, 9633 (2018). - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information

[1] Lee, N. & Hurt, A. C. Curr. Opin. Infect. Dis. 31, 520–526 (2018). - DOI

[2] Lee, N. & Hurt, A. C. Curr. Opin. Infect. Dis. 31, 520–526 (2018). - DOI

[3] Shtyrya, Y. A., Mochalova, L. V. & Bovin, N. V. Acta Naturae 2, 26–32 (2009). - DOI

[4] Shtyrya, Y. A., Mochalova, L. V. & Bovin, N. V. Acta Naturae 2, 26–32 (2009). - DOI

[5] FDA approves new drug to treat influenza. U. S. Food and Drug Administration https://www.fda.gov/news-events/press-announcements/fda-approves-new-dru... (2018).

[6] FDA approves new drug to treat influenza. U. S. Food and Drug Administration https://www.fda.gov/news-events/press-announcements/fda-approves-new-dru... (2018).

[7] Imai, M. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-019-0609-0 (2019).

[8] Imai, M. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-019-0609-0 (2019).

[9] Omoto, S. et al. Sci. Rep. 8, 9633 (2018). - DOI

[10] Omoto, S. et al. Sci. Rep. 8, 9633 (2018). - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Emerging antiviral resistance

Affiliations

Emerging antiviral resistance

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical